Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 3
1980 3
1981 5
1982 11
1983 26
1984 39
1985 49
1986 72
1987 54
1988 83
1989 96
1990 137
1991 133
1992 170
1993 210
1994 226
1995 276
1996 370
1997 362
1998 407
1999 402
2000 430
2001 480
2002 605
2003 731
2004 775
2005 975
2006 1097
2007 1206
2008 1272
2009 1348
2010 1489
2011 1497
2012 1663
2013 1721
2014 1816
2015 1869
2016 2013
2017 1926
2018 1924
2019 2020
2020 2097
2021 1954
2022 1758
2023 1718
2024 518

Text availability

Article attribute

Article type

Publication date

Search Results

33,910 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention.
Wong ND, Sattar N. Wong ND, et al. Nat Rev Cardiol. 2023 Oct;20(10):685-695. doi: 10.1038/s41569-023-00877-z. Epub 2023 May 16. Nat Rev Cardiol. 2023. PMID: 37193856 Review.
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality in individuals with type 2 diabetes mellitus (T2DM). ...Data from epidemiological studies and clinical trials demonstrate that successful control of multiple …
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality in individuals with type 2 d …
Precision medicine in the management of type 2 diabetes.
Gloyn AL, Drucker DJ. Gloyn AL, et al. Lancet Diabetes Endocrinol. 2018 Nov;6(11):891-900. doi: 10.1016/S2213-8587(18)30052-4. Epub 2018 Apr 23. Lancet Diabetes Endocrinol. 2018. PMID: 29699867 Review.
Simultaneously, several new drug classes with different mechanisms of action have been introduced over the past two decades, accompanied by data about cardiovascular safety and non-glycaemic outcomes. In this Review, we critically examine the progress and integratio …
Simultaneously, several new drug classes with different mechanisms of action have been introduced over the past two decades, accompanied by …
Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes.
Yun JS, Ko SH. Yun JS, et al. Metabolism. 2021 Oct;123:154838. doi: 10.1016/j.metabol.2021.154838. Epub 2021 Jul 30. Metabolism. 2021. PMID: 34333002 Free article. Review.
With the advances in diabetes care, the trend of incident cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) has been decreasing over past decades. ...This review will discuss the current epidemiologic tr …
With the advances in diabetes care, the trend of incident cardiovascular disease (CVD) in patients with type …
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
Htay T, Soe K, Lopez-Perez A, Doan AH, Romagosa MA, Aung K. Htay T, et al. Curr Cardiol Rep. 2019 Apr 22;21(6):45. doi: 10.1007/s11886-019-1133-9. Curr Cardiol Rep. 2019. PMID: 31011838 Review.
PURPOSE OF REVIEW: The aims of this review are to summarize recent data on mortality and cardiovascular disease (CVD) in type 1 and type 2 diabetes and to determine the interventions that could have contributed to a reduction in mortality. ...Despite a parallel tren …
PURPOSE OF REVIEW: The aims of this review are to summarize recent data on mortality and cardiovascular disease (CVD) in type 1 and t …
Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications.
Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, Standl E, Beulens JW. Dal Canto E, et al. Eur J Prev Cardiol. 2019 Dec;26(2_suppl):25-32. doi: 10.1177/2047487319878371. Epub 2019 Nov 13. Eur J Prev Cardiol. 2019. PMID: 31722562 Review.
Cardiovascular disease represents the principal cause of death and morbidity among people with diabetes, especially in those with type 2 diabetes mellitus. ...Given the substantial clinical impact of diabetes as a cardiovascular …
Cardiovascular disease represents the principal cause of death and morbidity among people with diabetes, especially in those w …
Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review.
Einarson TR, Acs A, Ludwig C, Panton UH. Einarson TR, et al. Value Health. 2018 Jul;21(7):881-890. doi: 10.1016/j.jval.2017.12.019. Epub 2018 Feb 16. Value Health. 2018. PMID: 30005761 Free article. Review.
BACKGROUND: Cardiovascular diseases (CVDs) constitute major comorbidities in type 2 diabetes mellitus (T2DM), contributing substantially to treatment costs for T2DM. ...RESULTS: Of 81 identified articles, 24 were accepted for analysis, of …
BACKGROUND: Cardiovascular diseases (CVDs) constitute major comorbidities in type 2 diabetes mellitus …
Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies.
Zhang Y, Pan XF, Chen J, Xia L, Cao A, Zhang Y, Wang J, Li H, Yang K, Guo K, He M, Pan A. Zhang Y, et al. Diabetologia. 2020 Jan;63(1):21-33. doi: 10.1007/s00125-019-04985-9. Epub 2019 Sep 4. Diabetologia. 2020. PMID: 31482198 Review.
AIMS/HYPOTHESIS: A healthy lifestyle has been widely recommended for the prevention and management of type 2 diabetes. However, no systematic review has summarised the relationship between combined lifestyle factors (including, but not limited to, smoking, alcohol drinking …
AIMS/HYPOTHESIS: A healthy lifestyle has been widely recommended for the prevention and management of type 2 diabetes. However, no sy …
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes.
Wilson JM, Nikooienejad A, Robins DA, Roell WC, Riesmeyer JS, Haupt A, Duffin KL, Taskinen MR, Ruotolo G. Wilson JM, et al. Diabetes Obes Metab. 2020 Dec;22(12):2451-2459. doi: 10.1111/dom.14174. Epub 2020 Sep 15. Diabetes Obes Metab. 2020. PMID: 33462955 Free PMC article. Clinical Trial.
AIM: To better understand the marked decrease in serum triglycerides observed with tirzepatide in patients with type 2 diabetes, additional lipoprotein-related biomarkers were measured post hoc in available samples from the same study. ...Lipoprotein particle profile by nu …
AIM: To better understand the marked decrease in serum triglycerides observed with tirzepatide in patients with type 2 diabetes, addi …
Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes.
Xu J, Rajaratnam R. Xu J, et al. Cardiovasc Diabetol. 2017 Feb 2;16(1):18. doi: 10.1186/s12933-017-0499-5. Cardiovasc Diabetol. 2017. PMID: 28148253 Free PMC article. Review.
Patients with type 2 diabetes mellitus have a twofold increased risk of cardiovascular mortality compared with non-diabetic individuals. ...The optimal approach to the reduction of cardiovascular risk in diabetic patients should fo …
Patients with type 2 diabetes mellitus have a twofold increased risk of cardiovascular mortality compared …
[Diabetes mellitus and cardiovascular prevention].
Kellerer M, Qui HJ. Kellerer M, et al. Dtsch Med Wochenschr. 2023 Aug;148(16):1033-1039. doi: 10.1055/a-1928-1360. Epub 2023 Aug 4. Dtsch Med Wochenschr. 2023. PMID: 37541293 Review. German.
About 90% of diabetes cases are due to type 2 diabetes mellitus (T2D). This form of diabetes is characterized by an increased release of proinflammatory adipokines, endothelial dysfunction and hyperglycemia, among others. ...This review a …
About 90% of diabetes cases are due to type 2 diabetes mellitus (T2D). This form of diabetes is ch …
33,910 results
You have reached the last available page of results. Please see the User Guide for more information.